Efficacy and Tolerability CVI (A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial (CVI)

Boehringer Ingelheim

Status and phase: Completed; Phase 3

Conditions: Venous Insufficiency

Treatments: Drug: Read vine leaf extract (AS 195)

Study type: Interventional

Funder types: Industry

Identifiers

NCT00292435

1138.10

Details and patient eligibility

About

To determine efficacy and tolerability of Antistax 360 mg tablets in chronic venous insufficiency linked to edema (swelling) and subjective symptoms

Sex

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria